Trends in pharmacological sciences
Gene therapy to the rescue in Parkinson's disease.
Valina L. Dawson, Ted M. Dawson, Allen S. Mandir
pág. 103
Gene therapy to the rescue in Parkinson's disease.
Jeffrey H. Kordower, Patrick Aebischer
pág. 105
Vasopeptidase inhibitors: an emerging class of cardiovascular drugs.: an emerging class of cardiovascular drugs.
Jean Bralet, Jean-Charles Schwartz
pág. 106
Cannabis: a pot of cellular actions in the mesolimbic system.: a pot of cellular actions in the mesolimbic system.
Chris Vaughan
pág. 110
To kill two birds with one stone: a general concept in gene regulation?: a general concept in gene regulation?
pág. 110
pág. 111
Rebecca Craven, David Cutler
pág. 111
Molecular determinants of metabotropic glutamate receptor signaling.
Antonio de Blasi, Peter Jeffrey Conn, Jean-Philippe Pin
pág. 114
Structure and function of GABA[sub c] receptors: a comparison of native versus recombinant receptors.: a comparison of native versus recombinant receptors.
Marc Awobuluyi
pág. 121
Orphan G-protein-coupled receptors and natural ligand discovery.
Andrew D. Howard, George McAllister, Scott D. Feighner
pág. 132
Arylamine N-acetyltransferases of mice, men and microorganisms.
Nichola Johnson, James Sandy, Anna Upton
pág. 140
Protease-activated receptors in inflammation, neuronal signaling and pain.
John L. Wallace, Nigel W. Bunnett, Nathalie Vergnolle
pág. 146
Oestrogen and the cardiovascular system: the good, the bad and the puzzling.: the good, the bad and the puzzling.
Gillian A. Gray, Isam Sharif, David J. Webb
pág. 152
A plethora of human genome sequences.
John P. Alsobrook II
pág. 157
- Página 1 de 1
